Consistent with previously reported findings, it has been demonstrated that TLR-4 signaling activation in HCC confers growth benefits by stimulating cytokine production and proliferation via the Akt and STAT3 pathways. The gene discussed is TLR4; the disease is hepatocellular carcinoma.